🟢 GRAIL is trading 5% up today with no confirmed GRAIL-specific catalyst

GRAIL is trading at $146.65, up +4.82%, with no confirmed company-specific explanation for the October 27 move.

• Previously announced ESMO presentations included a PATHFINDER 2 rapid oral session on October 26, but available sources do not establish it as the catalyst.
• The Nasdaq is up 0.61% in the supplied market context. Defensive investment interest in healthcare may also be contributing, though it does not confirm the reason for GRAIL’s move.